Novel technique for DSAEK yields thin grafts

Article

A novel technique for performing Descemet stripping automated endothelial keratoplasty (DSAEK) consistently yields thin grafts, according to recently published research in the British Journal of Ophthalmology.

A novel technique for performing Descemet stripping automated endothelial keratoplasty (DSAEK) consistently yields thin grafts, according to recently published research in the British Journal of Ophthalmology.

The team, led by Professor Joaquim Neto Murta (Ophthalmology Unit, Centro Hospitalar e Universitário de Coimbra, Praceta Mota Pinto, Coimbra, Portugal), prepared 25 DSAEK grafts using a novel technique. The technique involved two sequential cuts, the first of which was of variable thickness using a femtosecond laser and the second was performed using a 300 µm microkeratome head.

To analyse the new technique the team measured spectacle corrected visual acuity and endothelial cell density (with specular microscopy and anterior segment optical coherence tomography) at the periphery and the centre of the grafts both preoperatively and at 1, 3 and 6 months postoperatively.

No irregular cuts or perforations occurred during tissue preparation and the team found that central graft thickness was 79.6 µm and 69.3 µm at 3 and 6 months respectively. Spectacle corrected distance visual acuity was found to improve from 0.91 logMAR preoperatively to 0.11 logMAR at 6 months post-op.

In conclusion, the novel technique was deemed to provide consistently thin grafts of lower than 100 µm and good visual acuity outcomes. Additionally, no graft detachments were encountered and so there was no wastage of donor tissue.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
© 2025 MJH Life Sciences

All rights reserved.